We are live on ! Find out more
QGENF

QIAGEN NV
QGENF

Delisted

QGENF was delisted on the 14th of February, 2005.

6 hedge funds and large institutions have $22.6M invested in QIAGEN NV in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 179 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% less funds holding in top 10

Funds holding in top 10: 41 (-3)

97% less funds holding

Funds holding: 1896 (-183)

98% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 179

99% less capital invested

Capital invested by funds: $2.59B → $22.6M (-$2.57B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
6
Holders Change
-183
Holders Change %
-96.83%
% of All Funds
0.15%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
3
Increased
Reduced
3
Closed
179
Calls
Puts
Net Calls
Net Calls Change

QGENF Hedge Fund Activity: Q1 2017 in Review

6 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q1 2017, worth a combined $22.6M — down 99% from $2.59B a quarter earlier.

Sellers outnumbered buyers: 179 funds closed out of QGENF and 3 opened new positions — a net loss of 176 holders — while 3 trimmed existing stakes and 0 added.

The largest buyer was Pura Vida Investments, opening a new position worth an estimated $4.42M. The largest seller was Deutsche Bank, exiting entirely with an estimated $278M sold.

  • 6 institutional investors held QIAGEN NV (QGENF) as of Q1 2017, down from 189 in Q4 2016.
  • Funds reported $22.6M of QIAGEN NV stock for Q1 2017, down 99% quarter-over-quarter.
  • 3 funds opened new QIAGEN NV positions in Q1 2017 and 179 closed out, a net change of -176 holders.
  • The largest QIAGEN NV buyer in Q1 2017 was Pura Vida Investments, an estimated $4.42M added.
  • The largest QIAGEN NV seller in Q1 2017 was Deutsche Bank, an estimated $278M sold.

Based on aggregated 13F filings for Q1 2017.